Prilosec and Intercapillary glomerulosclerosis - a phase IV clinical study of FDA data

Summary:

Intercapillary glomerulosclerosis is reported as a side effect among people who take Prilosec (omeprazole), especially for people who are female, 50-59 old, have been taking the drug for 5 - 10 years also take Prevacid 24 Hr,.

The phase IV clinical study analyzes which people have Intercapillary glomerulosclerosis when taking Prilosec. It is created by eHealthMe based on reports of 171,578 people who have side effects when taking Prilosec from the FDA, and is updated regularly.

What is Prilosec?

Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 175,285 Prilosec users. Check the latest studies of Prilosec.

What is Intercapillary glomerulosclerosis?

Intercapillary glomerulosclerosis (progressive kidney disease caused by angiopathy of capillaries in the kidney glomeruli) is found to be associated with 26 drugs and 72 conditions by eHealthMe. Check the latest studies of Intercapillary glomerulosclerosis.

On Jul, 09, 2026

171,578 people reported to have side effects when taking Prilosec.
Among them, 17 people (0.01%) have Intercapillary glomerulosclerosis.

Could Prilosec cause Intercapillary glomerulosclerosis?

Among these 17 people:

How long have people been on Prilosec when they have Intercapillary glomerulosclerosis? *

What is the gender of people who have Intercapillary glomerulosclerosis when taking Prilosec? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Intercapillary glomerulosclerosis when taking Prilosec? *

What are other drugs people take besides Prilosec? *

What are other side effects people have besides Intercapillary glomerulosclerosis? *

Chronic Kidney Disease: 16 people, 94.12%
Acute Kidney Failure: 15 people, 88.24%
Renal Impairment (severely reduced kidney function): 15 people, 88.24%
Diabetic Nephropathy (diabetic kidney disease): 15 people, 88.24%
Hypertensive Nephropathy (hypertensive renal disease): 14 people, 82.35%
Renal Cyst (kidney cyst): 14 people, 82.35%
Nephrogenic Anaemia (anaemia due to kidney disease): 12 people, 70.59%
Urination - Excessive At Night: 12 people, 70.59%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 11 people, 64.71%
Focal Segmental Glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli): 11 people, 64.71%

* Approximation only. Some reports may have incomplete information.

Do you take Prilosec and have Intercapillary glomerulosclerosis?

- Check whether Intercapillary glomerulosclerosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prilosec:

Prilosec (175,285 reports)

Browse all side effects of Prilosec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intercapillary glomerulosclerosis:

Intercapillary glomerulosclerosis (26 drugs)

Browse all the conditions that are associated with Intercapillary glomerulosclerosis:

Intercapillary glomerulosclerosis (72 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole (the active ingredients of Prilosec) and Prilosec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.